JIA Voice of the Patient

The Arthritis Foundation and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) host a patient-focused drug development meeting.

The world’s largest network of arthritis patients – the Arthritis Foundation, and the largest network of pediatric rheumatologists – the Childhood Arthritis and Rheumatology Research Alliance (CARRA) hosted the externally-led Juvenile Idiopathic Arthritis (JIA) Patient-Focused Drug Development (PFDD) meeting in Washington, D.C. on August 2, 2018. Families from around the country, FDA staff, industry leaders, and researchers attended in person and virtually via webinar. 

This meeting provided the U.S. Food and Drug Administration (FDA), drug developers, health care providers, academic researchers, and other stakeholders an opportunity to hear directly from patients, patient advocates and caretakers about the signs and symptoms that matter most to them. JIA parents and their families shared information about the impact of JIA on daily life, the most challenging symptoms, experiences with currently available treatments and the need for new and different treatments.  

Before the meeting, the Arthritis Foundation reached out to patients and their families from all over the country to obtain background information. A total of five focus groups and close to 600 families responded to survey questions to provide more about patient experiences and concerns. Some of the vital information about the burden of disease and treatment options gathered include: 

Most common symptoms that cause the most significant burden were pain and fatigue, followed by swelling, stiffness, limited range of motion, and among systemic JIA families, fevers and rashes. 

Over 3 in 4 patients report pain as the JIA symptom with the biggest impact on their daily life. 

Over a third of patients say pain and fatigue are not satisfactorily addressed with current treatments. 

Parents frequently raised mental and emotional health issues; young adults were more focused on specific joint symptoms and related functional losses. 

All groups spoke on the impact on ability to participate in sports. Parents raised concerns about reduced capability to participate in school and social activities; young adults were more focused on impacts on work, driving, and use of assistive technology. 

Over 3 in 4 patients have used non-prescribed treatments to help reduce symptoms of JIA .

An “ideal” drug is one with oral administration, and little to no side effects—how the drug affects reproductive health is a concern. Reduced frequency of treatment was also desired. 

The JIA Voice of the Patient Report is an overview of results from this meeting, the background information collected prior to the meeting and stories shared by the patients and parents who participated in the meeting.

To learn more, watch the August 2, 2018 meeting: 

 

Juvenile Arthritis Patient-Focused Drug Development Meeting - Part 1
Hundreds of patients and their families, FDA staff, industry leaders and researchers participated in the externally-led Juvenile Idiopathic Arthritis (JIA) Patient-Focused Drug Development meeting in Washington, DC, on Aug. 2, 2018. Patients and parents shared information about the impact of JIA on daily life, the most challenging symptoms, experiences with currently available treatments and the need for new and different treatments. Learn more at https://bit.ly/2x0O9rY.
Juvenile Arthritis Patient-Focused Drug Development Meeting - Part 2
Hundreds of patients and their families, FDA staff, industry leaders and researchers participated in the externally-led Juvenile Idiopathic Arthritis (JIA) Patient-Focused Drug Development meeting in Washington, DC, on Aug. 2, 2018. In Part 2 of the meeting, patients and parents shared their perspectives on current treatment approaches and clinical trial design. Learn more at https://bit.ly/2x0O9rY.
Live Yes! INSIGHTS

By giving us 10 minutes, you become part of a force that will change the lives of the more than 54 million people with arthritis. Your voice matters.

I Want to Contribute
I Need Help
  • Donate

    Donate

    Every gift to the Arthritis Foundation will help people with arthritis across the U.S. live their best life.

  • Volunteer

    Volunteer

    Join us and become a Champion of Yes. There are many volunteer opportunities available.

  • Live Yes! INSIGHTS

    Live Yes! INSIGHTS

    Take part to be among those changing lives today and changing the future of arthritis.

  • Partner

    Partner

    Proud Partners of the Arthritis Foundation make an annual commitment to directly support the Foundation’s mission.

Donate


Make a Donation

Help millions of people live with less pain and fund groundbreaking research to discover a cure for this devastating disease. Please, make your urgently-needed donation to the Arthritis Foundation now!

Become a Member

Become an Arthritis Foundation member today for just $20. You'll receive a year's worth of Arthritis Today magazine, access to helpful tools, resources, and more.

Make a Honor or Memorial Gift

Honor a loved one with a meaningful donation to the Arthritis Foundation. We'll send a handwritten card to the honoree or their family notifying them of your thoughtful gift.

Volunteer


Volunteer Opportunities

The Arthritis Foundation is focused on finding a cure and championing the fight against arthritis with life-changing information, advocacy, science and community. We can only achieve these goals with your help. Strong, outspoken and engaged volunteers will help us conquer arthritis. By getting involved, you become a leader in our organization and help make a difference in the lives of millions. Join us and become a Champion of Yes.


More About Volunteering

Live Yes! INSIGHTS


Give Just 10 Minutes.

Tell us what matters most to you. Change the future of arthritis.

By taking part in the Live Yes! INSIGHTS assessment, you’ll be among those changing lives today and changing the future of arthritis, for yourself and for 54 million others. And all it takes is just 10 minutes.

Your shared experiences will help:

- Lead to more effective treatments and outcomes
- Develop programs to meet the needs of you and your community
- Shape a powerful agenda that fights for you

Now is the time to make your voice count, for yourself and the entire arthritis community. 

Currently this program is for the adult arthritis community.  Since the needs of the juvenile arthritis (JA) community are unique, we are currently working with experts to develop a customized experience for JA families. 


How are you changing the future?

By sharing your experience, you’re showing decision-makers the realities of living with arthritis, paving the way for change. You’re helping break down barriers to care, inform research and create resources that make a difference in people’s lives, including your own.

Get Started

 

Partner


Meet Our Partners

As a partner, you will help the Arthritis Foundation provide life-changing resources, science, advocacy and community connections for people with arthritis, the nations leading cause of disability. Join us today and help lead the way as a Champion of Yes.

Trailblazer

Our Trailblazers are committed partners ready to lead the way, take action and fight for everyday victories. They contribute $2,000,000 to $2,749,000

Visionary

Our Visionary partners help us plan for a future that includes a cure for arthritis. These inspired and inventive champions have contributed $1,500,00 to $1,999,999.

Pioneer

Our Pioneers are always ready to explore and find new weapons in the fight against arthritis. They contribute $1,000,000 to $1,499,999.

Pacesetter

Our Pacesetters ensure that we can chart the course for a cure for those who live with arthritis. They contribute $500,000 to $999,000.

Signature

Our Signature partners make their mark by helping us identify new and meaningful resources for people with arthritis. They contribute $250,000 to $499,999.

Supporting

Our Supporting partners are active champions who provide encouragement and assistance to the arthritis community. They contribute $100,000 to $249,999.

More About Partnerships